Letters Hormone replacement therapy

HRT in premature menopause

BMJ 2008; 337 doi: https://doi.org/10.1136/bmj.a1668 (Published 16 September 2008) Cite this as: BMJ 2008;337:a1668
  1. Margaret C P Rees, reader in reproductive medicine, University of Oxford1
  1. 1Women’s Centre, John Radcliffe Hospital, Oxford OX3 9DU
  1. margaret.rees{at}obs-gyn.ox.ac.uk

    Grant’s blanket statement,1 based on the WISDOM study,2 that “it would be irresponsible to think that any use of hormone replacement therapy (HRT) is justifiable” will confuse those dealing with women with early ovarian failure in their 20s and 30s. National guidelines recommend the use of HRT in this group until the average age of the natural menopause in the early 50s.3 The results of the WISDOM study, which randomised women with a mean age of 63.8 years, should not be extrapolated to them.

    Notes

    Cite this as: BMJ 2008;337:a1668

    Footnotes

    • Competing interests: None declared.

    References

    View Abstract

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe